ClinicalTrials.Veeva

Menu

CCC Project - Atrial Fibrillation

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status

Completed

Conditions

Atrial Fibrillation

Study type

Observational

Funder types

Other

Identifiers

NCT02309398
CCC-AF-2014

Details and patient eligibility

About

The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.

Enrollment

67,028 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalized patients with discharge diagnosis as atrial fibrillation in 150 tertiary and 100 secondary hospitals.

Exclusion criteria

None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems